Metamark Genetics logo — Metamark - A leader in comprehensive urology cancer care

Metamark Genetics

Metamark - A leader in comprehensive urology cancer care

Founded 2007 United States Cambridge, United States 23 employees Growth Total: $33.80M Biotechnology, Health Care +1

General Information

Company Name Metamark Genetics
Founded Year 2007
Location United States Cambridge, United States +1
Founders / Decision Makers
Ronald A. DePinho  — Founder
Employees 23
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Growth
Social

Get notified when Metamark Genetics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Metamark Genetics

Metamark Genetics, established in 2007, positions itself as a frontrunner in the field of comprehensive urology cancer care. With its slogan "Metamark - A leader in comprehensive urology cancer care," the company is anchored in breakthrough diagnostic and prognostic testing aimed at enhancing cancer treatment outcomes.

Headquartered in the United States, Metamark operates within the Biotechnology, Health Care, and Health and Wellness industries. Since inception, the firm has made significant strides in clinical proteomics, focusing particularly on prostate and bladder cancer, leveraging its deep expertise in molecular diagnostics.

The company last secured a $13.00M Series B investment on 05 November 2012, which supports its ongoing innovation and expansion endeavors.

Taxonomy: Urology Cancer Care, Prostate Cancer Diagnosis, Bladder Cancer Management, Clinical Proteomics, Molecular Diagnostics, Personalized Medicine, Prognostic Testing, Predictive Diagnostic Tests, Prognosis Determinants Platform, ProMark, Cancer Progression Analysis, Metastasis Research, Tumor Stratification

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Growth Equity Vc $9.10M - 01 Nov 2012
Series B $22.00M 1 01 Aug 2010
Early VC $2.70M - 01 May 2009

Metamark Genetics Alternatives & Competitors

Metamark Genetics vs

Eliminating cancer misdiagnosis by launching a new diagnostic test in 2023 and operating a boutique...

Grant
37 employees
Biotechnology, Health Care
Metamark Genetics vs
Oncobit AG
Oncobit AG Switzerland

Enabling personalized cancer care

Seed
15 employees
Biotechnology, Health Care
Metamark Genetics vs
Vortex Biosciences
Vortex Biosciences United States

Circulating Tumor Cells (CTCs) are cancer cells, which have detached from the primary tumor and have...

Series Unknown
7 employees
Biotechnology, Health Care

FAQ About Metamark Genetics

Metamark - A leader in comprehensive urology cancer care
Metamark Genetics was founded in 2007.
Metamark Genetics is headquartered in Cambridge, United States.
Metamark Genetics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Metamark Genetics has approximately 23 employees.
Metamark Genetics has completed 3 funding rounds, raising a total of $33.80M. The latest funding stage is Growth.
Top alternatives and competitors to Metamark Genetics include MultiplexDX International, Oncobit AG, Vortex Biosciences, Nucleix Ltd., Breathonix Pte Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Metamark Genetics and MultiplexDX International are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Metamark Genetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy